We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Roche, Mylan Settle Suit Over Generic Cancer Drug

Law360, New York (September 21, 2011, 7:36 PM EDT) -- Hoffmann-La Roche Inc. and Mylan Inc. on Tuesday reached a settlement over claims that Mylan infringed a Roche patent by marketing a generic version of cancer drug Xeloda.

Mylan said Wednesday that the companies had reached a settlement and licensing agreement over Mylan's production of generic capecitabine tablets, which are used as a chemotherapy agent.

The agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, Mylan said. Terms of the settlement were not disclosed.

Roche sued Canonsburg, Pa.-based Mylan...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.